Skip to main content
SpringerLink
Log in

Background

  • Chapter
  • First Online:
Maternal Drug Use and Infant Congenital Malformations

  • 388 Accesses

Abstract

In this chapter, various methodological aspects and the most common sources of information in the literature are briefly discussed. Different methods of ascertainment of congenital malformations and of drug exposure are described, the problem of confounding and of mass significance. A detailed description of the system used when analyzing the Swedish health registers with its positive and negative aspects is given.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P, Safe-Med Study Group. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 2010;95:E337–41.

    Article  Google Scholar 

  • Cunnington MC, Well JG, Messerheimer JA, Ferber S, Yerby M, Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology. 2011;76:1817–23.

    Article  CAS  Google Scholar 

  • Czeizel AE. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol. 1987–1988;1:183–8.

    Article  Google Scholar 

  • Dolk H, Jentink J, Loane M, Morris J, de Jong van den Berg LT, EUROCAT Antieplieptic Drug Working Group. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology. 2008;71:714–22.

    Article  CAS  Google Scholar 

  • Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group Inc.; 1977.

    Google Scholar 

  • Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy register: a 6-year experience. Arch Neurol. 2004;61:673–8.

    Article  Google Scholar 

  • Källén B. A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand. 1986;73:253–9.

    Article  Google Scholar 

  • Källén B. A prospective study of some aetiological factors in limb reduction defects in Sweden. J Epidemiol Commun Health. 1989;43:86–91.

    Article  Google Scholar 

  • Källén B. Drugs during pregnancy. New York: Nova Biomedical Books; 2009.

    Google Scholar 

  • Källén B. Epidemiology of human congenital malformations. Berlin: Springer; 2014. https://doi.org/10.1007/978-3-319-01472-2.

    Book  Google Scholar 

  • Källén B. Drugs during pregnancy. Methodological aspects. Springer; 2016. https://doi.org/10.1007/978-3-319-40697-8.

    Book  Google Scholar 

  • Källén B, Nilsson E, Otterblad Olausson P. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur J Clin Pharmacol. 2011;67:839–45.

    Article  Google Scholar 

  • Levy A, Malok I, Gorodischer R, Sherf M, Wiznitzer A, Lisziel E, Koren G. Bias towards the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists. J Clin Pharmacol. 2012;52:78–83.

    Article  CAS  Google Scholar 

  • Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C. The norwegian mother and child cohort study (MoBa). Int J Epidemiol. 2006;35:1146–50.

    Article  Google Scholar 

  • Mitchell AA, Rosenberg L, Shapiro S, Slone D. Birth defects related to bendectin use in pregnancy. JAMA. 1981;245:311–4.

    Article  Google Scholar 

  • Olsen J. The danish national birth cohort—the background, structure and aim. Scand J Publ Health. 2001;29:300–7.

    Article  CAS  Google Scholar 

  • Russell AJC, Craig JJ, Morrison P, Irwin B, Waddell R, Parsons L, Robertson I, Guthrie E, Morrow JI. U.K. epilepsy and pregnancy group. Epilepsia. 2004;45:1467.

    Article  Google Scholar 

  • Robert E, Vollset SE, Botto L, Lancaster PA, Merlob P, Mastroiacovo P. Malformation surveillance and maternal drug exposure. Int J Risk Saf Med. 1994;6:75–118.

    CAS  Google Scholar 

  • Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden—assessed by the prescribed drug register and the medical birth register. Clin Epidemiol. 2011;3:43–50.

    Article  Google Scholar 

  • Thomas SV, Jose M, Divarakaran S, Sarma PS. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017;58(2):274–81. https://doi.org/10.1111/epi.13632.

    Article  CAS  PubMed  Google Scholar 

  • Tomson T, Xue H, Battino D. Major congenital malformations in children of women with epilepsy. Seizure. 2015;28:46–50.

    Article  Google Scholar 

  • Vajda FJ, Hitchcock A, Graham J, O’Brien T, Lander C, Eadie M. The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol. 2007;47:468–74.

    Article  Google Scholar 

  • Wolgast E, Josefsson A, Josefsson M, Liliecreutz C, Reis M. Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drug in plasma. Eur J Clin Pharmacol. 2018;74:535–9.

    Article  CAS  Google Scholar 

  • Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. The national birth defects prevention study. Public Health Rep. 2001;116(Suppl 1):32–40.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    Bengt Källén

Authors
  1. Bengt Källén
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Källén, B. (2019). Background. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17898-7_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17897-0

  • Online ISBN: 978-3-030-17898-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation